Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway
Figure 4
Effects of EGCG on the protein level of the endogenous inhibitor TIMP-2 and RECK. (a) M17 cells were treated with EGCG (0–100 μM) for 24 hours and then subjected to western blotting to analyze the protein levels of TIMP-2 and RECK, respectively. (b) Quantitative results of TIMP-2 and RECK protein levels which were adjusted with β-actin protein level. The values represented the means ± SD of at least three independent experiments. as compared with the vehicle group.
